Dronabinol (synthetic THC) safely and effectively reduced agitation in Alzheimer's patients over 3 weeks, with a medium effect size and no increase in intoxication or cognitive decline.
Geriatric psychiatrists, Alzheimer's caregivers, and anyone interested in cannabinoid therapeutics for dementia.
Effect size 0.53 on agitation with favorable safety
What the researchers found
In a 3-week RCT of 75 Alzheimer's patients, dronabinol decreased agitation significantly more than placebo on the Pittsburgh Agitation Scale (effect size 0.53, p=0.015). The NPI-C agitation/aggression measure showed a trend (effect size 0.36, p=0.094). 84% completed the trial. Dronabinol was not associated with greater intoxication, cognitive decline, or adverse events except somnolence.
Why it matters
Agitation in Alzheimer's is extremely common and distressing, and current treatments have limited effectiveness with serious safety concerns including increased mortality risk. Dronabinol showed clinically meaningful agitation reduction with a favorable safety profile.
The numbers in context
75 participants across 5 sites. PAS decline: -0.74/week between arms (p=0.015, effect size 0.53). NPI-C A/A decline: -1.26 (p=0.094, effect size 0.36). 84% completion rate. Target dose: 10 mg/day. 9% Black, 11% Hispanic. No increase in intoxication, falls, or cognitive decline.
How the study worked
Multicenter (5 sites), 3-week, randomized, parallel, double-blind, placebo-controlled trial. Dronabinol titrated up to 10 mg daily in divided doses. 75 participants meeting criteria for agitation of Alzheimer's disease.
What this study cannot tell us
Only 3 weeks duration. Most participants were on concomitant psychotropics. Moderate sample size. One of two primary outcomes did not reach significance. Long-term safety and efficacy unknown.
How to read the evidence
Well-designed multicenter double-blind RCT with racially diverse sample, published in American Journal of Geriatric Psychiatry. Moderate sample size but rigorous methodology.
When this study was published
2026 publication of trial conducted 2017-2024.
The bigger picture
This is a landmark trial as the first large randomized study of dronabinol for Alzheimer's agitation. The FDA approved pimavanserin for this indication in 2024, but options remain limited. Dronabinol could become an important addition to the treatment toolkit.
Questions still open
- Would longer treatment show sustained or enhanced benefits? Could dronabinol reduce the need for antipsychotics in Alzheimer's patients? What is the optimal dose for balancing efficacy and somnolence?
Common questions
Can THC help Alzheimer's agitation?
Did patients get "high" from the medication?
Read the original research
A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 34(2), 167-179
Citation
Rosenberg, Paul B; Amjad, Halima; Burhanullah, Haroon; Nowrangi, Milap; Vandrey, Ryan; Pierre, Mersania Jn; Outen, John D; Schultz, Meghan; Marano, Christopher; Agronin, Marc; Wilkins, James M; Harper, David; Laffaye, Todd; Reardon, Eilis; Turner, Kathryn; Ozonsi, Rosain; Drury, Mia; Nguyen, Andre; Hasoğlu, Tuna; Cromwell, Julia; Leoutsakos, Jeannie-Marie; Forester, Brent P. (2026). A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease.. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 34(2), 167-179. https://doi.org/10.1016/j.jagp.2025.10.011
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk